$1.8 MM EBITDA Pharma Company Seeking Sale of Control Stake

Transaction Overview Spektrum Capital is seeking sale of control stake ▪ Fully Integrated Specialty Pharma firm with end to end Prescription Generics drug development, Manufacturing and Commercialization ▪ 2020 Revenue $8.7M, with an adj EBIDA of $1.82M (1) ▪ Strong marketing partners network with ANDA portfolio of 70+ drugs, with 29 approved as of April###-###-#### ). ▪ 25000 sq.ft manufacturing facility with an additional###-###-#### sq.ft available for expansion(1) ▪ #50+ employees ▪ Experienced team of founders, with a proven track record of scaling up Outsourced services business. ▪ With new ANDA approvals, the firm expects revenue, profits and cashflow to improve significantly (1).